Skip to main content
Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
4.570
+0.040 (0.88%)
At close: Mar 9, 2026, 4:00 PM EDT
4.660
+0.090 (1.97%)
After-hours: Mar 9, 2026, 7:52 PM EDT

Atossa Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
15
Market Cap
39.35M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Atara Biotherapeutics 151.93M
Xilio Therapeutics 31.80M
Veru Inc. 16.89M
Palatin Technologies 8.96M
CervoMed 6.16M
Lisata Therapeutics 1.07M
Actinium Pharmaceuticals 90.00K
Revenue Rankings

ATOS News

More News